weight regain and cardiometabolic effects after withdrawal of semaglutide What a new obesity drug candidate! https://lnkd.in/ej5xH_9w Trajectory of weight regain after

Each system has its own activation threshold, adaptation timeline, and dose-response relationship

Clinical trials of FDA-approved semaglutide and tirzepatide show average weight loss of 1521% of total body weight, far beyond what lifestyle changes alone typically achieve (individual results vary and are not guaranteed)

But oral GLP-1 pills are on the horizon and could soon offer a simpler, more flexible option for weight loss

Start your intake How Semaglutide Weekly Dosing Actually Works Semaglutide is a long-acting GLP-1 receptor agonist with a half-life of approximately seven days, meaning the medication remains active in your body for an extended period after each injection